For the Quarter Ending September 2025
North America
• In United States, the Luliconazole Price Index rose quarter-over-quarter in Q3 2025, driven by increased production costs and robust demand.
• Production costs for Luliconazole increased in Q3 2025, influenced by a 2.6% year-over-year PPI rise in August 2025.
• Input and energy costs for chemical manufacturing climbed in Q3 2025, with natural gas prices rising August to September.
• US antifungal drugs market demand strengthened in Q3 2025, supported by a 5.42% year-over-year retail sales increase in September 2025.
• Consumer confidence declined to 94.2 in September 2025, yet a 4.3% unemployment rate supported purchasing power.
• Chemical manufacturers' inventories tightened in Q3 2025 due to accelerated destocking, affecting Luliconazole supply.
• Industrial production growth was sluggish at 0.1% year-over-year in September 2025, indicating slower overall manufacturing activity.
• The Luliconazole Price Index is forecast to maintain an upward trend, given persistent cost pressures and steady demand drivers.
Why did the price of Luliconazole change in September 2025 in North America?
• Rising input costs, with a 2.6% PPI increase in August 2025, elevated Luliconazole production expenses.
• Strong consumer demand, supported by a 5.42% retail sales increase in September 2025, boosted market pull.
• Tightening chemical manufacturer inventories in Q3 2025 contributed to supply constraints for Luliconazole.
Europe
• In Germany, the Luliconazole Price Index fell quarter-over-quarter in Q3 2025, driven by declining producer prices and feedstock costs.
• Luliconazole production costs decreased in Q3 2025, as producer prices for basic chemicals declined by 1.7% in September 2025.
• Demand for Luliconazole strengthened in Q3 2025, supported by firming pharmaceutical output and 0.8% retail sales growth.
• The Luliconazole Price Forecast faces pressure from contracting industrial production, down 1.0% year-on-year in September 2025.
• High operating costs, from 2.4% CPI year-on-year in September 2025, partially offset lower petrochemical feedstock benefits.
• Chemical industry inventories shrank in Q3 2025 due to accelerating destocking efforts, impacting supply.
• Increased imports of pharmaceutical products into Germany in Q3 2025 intensified domestic market competition.
• A contracting Manufacturing Index in September 2025 reflected a broader economic slowdown.
• Low 3.9% unemployment in September 2025 supported consumer purchasing, despite low consumer confidence (-23.6 index).
Why did the price of Luliconazole change in September 2025 in Europe?
• Producer prices for basic chemicals declined 1.7%, reducing Luliconazole manufacturing input costs.
• Increased pharmaceutical imports intensified domestic market competition.
• High operating costs, from 2.4% CPI, pressured chemical industry profitability.
APAC
• In China, the Luliconazole Price Index fell quarter-over-quarter in Q3 2025, influenced by deflationary CPI (-0.3%) in September.
• Luliconazole production costs declined during Q3 2025, driven by a -2.3% PPI in September 2025 and falling coal prices.
• Demand for Luliconazole was supported by a thriving pharmaceutical market and rising healthcare spending in Q3 2025.
• Consumer confidence at 89.6 in September 2025 indicated pessimism, tempering Luliconazole demand in the OTC segment.
• China's industrial production increased by 6.5% year-on-year in September 2025, signaling robust economic activity.
• Retail sales grew by 3.0% year-on-year in September 2025, indicating stable consumer demand for healthcare products.
• Trade flows for APIs faced disruptions in Q3 2025 due to port congestion and ongoing U.S.-China trade tensions.
• The Manufacturing Index contracted in September 2025, reflecting a general slowdown in the broader industrial sector.
Why did the price of Luliconazole change in September 2025 in APAC?
• Deflationary CPI (-0.3%) in September 2025 exerted downward pressure on Luliconazole market prices.
• Luliconazole production costs decreased due to -2.3% PPI and falling coal prices in Q3 2025.
• Mixed demand signals, with stable retail sales (3.0%) but contracting consumer confidence (89.6) in September.
For the Quarter Ending December 2022
North America
Luliconazole API had shifting market patterns in the North American region during the fourth quarter of 2022. Beginning with Q4 2022, prices were predicted to rise through the second month of the quarter due to a high cost of manufacturing, numerous logistical problems, and rising inflation.
Additionally, the market position was maintained well by rising transportation costs and port congestion at the major ports. Prices begin to decline later in December because of softening inflation and declining end-user sector demand. During the month of December, the settlement price of Luliconazole API came down to USD 463500/MT CFR in New York.
Asia
In the fourth quarter of 2022, the Luliconazole API market witnessed fluctuating trajectory in the Asia Pacific region. At the commencement of Q4 2022, the prices were recorded to increase till the second month of Q4 on the back of increasing demand from the end-user sector and several logistic issues. Also, the strict zero covid policies and repeated lockdowns in the Chinese provinces affected the market situation. The increased production cost on the back of rising energy prices and increased domestic manufacturing to cater to regional and international orders kept the market tight. However, later in the month of December, the prices of Luliconazole API went down as the domestic merchants had enough inventories on their shelves. During the month of December, the settlement price of Luliconazole API came down to USD 390050/MT FOB Shanghai.
Europe
In the Fourth quarter of 2022, the prices of Luliconazole API showcased a see-saw trajectory in the European region. The downstream pharmaceutical sector's demand for Luliconazole API was recorded to be consistent. However, the ongoing port congestion and supply disruption in the European region affected the supply chain and compelled the prices to increase in the first two months of Q4 2022. Also, the high freight charges contributed to the hiked-up trajectory of Luliconazole API. Nevertheless, the prices drop in the month of December owing to existing inventories and lowering demand from the end-user sector. During the month of December, the settlement price of Luliconazole API came down to USD 429000/MT CFR Hamburg.
For the Quarter Ending September 2022
North America
In North America, the Luliconazole market experienced a stable trajectory throughout the third quarter of 2022 due to steady demand from the end-user pharmaceutical sector. The feedstock Dichlorobenzene witnessed firm market sentiments globally. Since the North American region relies on Asian countries for the stock supply, hampered supply prompted product unavailability in the regional market also affected the Luliconazole price in the US market. The prices went consistent owing to stable freight charges, withdrawal of policies etc. With loosening supply, enough inventories, and steady demand, Luliconazole prices decreased gradually. Towards the end of Q3 2022, the price trend of Luliconazole was recorded to be USD 458055/MT, with an average quarterly declination of 0.99%.
Asia
Since the beginning of this quarter, there has been a stable demand for Luliconazole on a global level due to consistent market demand and improving market sentiment. Growing demand from downstream pharmaceutical businesses helped Luliconazole dynamics. Due to stable demand and sufficient stockpiles, the market emotions for the raw material Dichlorobenzene were also adaptable. Due to a shortage of demand from local and international markets, prices started to decline gradually from the beginning of Q3 2022. When the adequate inventory was restocked, the cost remained low. Prices were recorded as USD 385990/MT at the end of Q2 2022, with a quarterly decline of 2.01%.
Europe
Prices for Luliconazole were observed to be declining as Q3 2022 came to a close. The global firm prices for feed Dichlorobenzene demonstrated a steady market trajectory. Due to hampered transportation and route interruption brought on by geopolitical unrest during the Russia-Ukraine war, prices were on the slightly higher side of the trend at the beginning of the first half of Q3 2022. In addition, the stabilization of Feedstock Dichlorobenzene pricing maintained the Luliconazole market calm in the latter two months of Q3. Prices were recorded as being USD 421780/MT at the end of Q3 2022, with an average quarterly decline of 1.31%.
For the Quarter Ending June 2022
North America
In North America, the Luliconazole market showcased a stable trajectory throughout the quarter due to steady demand from the downstream pharmaceutical sector. The raw material dichlorobenzene market witnessed increased market sentiments globally. Since the North American region relies on the Asian countries for the stock supply, hampered supply prompted the product unavailability in the regional market. With the commencement of the second half of Q2, the prices went stable owing to stable freight charges, withdrawal of policies, and ease in route disruption. With loosening supply, enough inventories, and steady demand, luliconazole prices decreased gradually. Towards the end of Q2 2022, the price trend of luliconazole was recorded to be USD 472140/MT , with the quarterly inclination of 5.85%.
Asia
Global demand for luliconazole has been stable since the beginning of this quarter, owing to steady market demand and improved market sentiments. The dynamics of luliconazole were supported by growing demand from downstream pharmaceutical industries. Also, the market sentiments of raw material dichlorobenzene were flexible owing to stable demand and enough inventories. At the onset of the second half of Q2 2022, the prices decreased gradually due to a lack of demand from regional and overseas markets. With the destocking of enough inventories, the cost remained feeble. Towards the termination of Q2 2022, the prices were recorded to be USD 410345/MT with a quarterly declination of 0.21%.
Europe
Prices of Luliconazole were recorded in ascending trend towards the termination of Q2 2022. The prices of feeds dichlorobenzene showcased an upward market trajectory with firm prices globally. At the commencement of the first half of Q2 2022, hindered transportation and route disruption owing to geopolitical tension following the Russia-Ukraine war affected the prices to be on the higher side of the trajectory. Furthermore, stabilization in the prices of Feedstock Dichlorobenzene kept the market of luliconazole at ease. Towards the termination of Q2 2022, the prices were recorded to be USD 438900/MT with a quarterly inclination of 3.08%.
